adenosine monophosphate has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Li, J; Li, Q; Liu, W; Qian, J; Wang, J; Wu, D | 1 |
| Kaur, M; Mukhopadhyay, K; Sidana, V; Tiwari, D | 1 |
2 other study(ies) available for adenosine monophosphate and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
Topics: Adenosine Monophosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury, Chronic; Cyclooxygenase 2; Cytochromes c; Dexmedetomidine; Glutathione; MAP Kinase Signaling System; MicroRNAs; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2022 |
Remdesivir-Induced Liver Injury in a COVID-Positive Newborn.
Topics: Adenosine Monophosphate; Alanine; Chemical and Drug Induced Liver Injury, Chronic; COVID-19 Drug Treatment; Humans; Infant, Newborn | 2022 |